Patients with Cushing's syndrome have increased intimal media thickness at different vascular levels: Comparison with a population matched for similar cardiovascular risk factors

Hormone and Metabolic Research

Volumn 38, Issue 6, 2006, Pages 405-410

  Albiger, N ^a   Testa, R M ^a   Almoto, B ^a   Ferrari, M ^a   Bilora, F ^b   Petrobelli, F ^b   Pagnan, A ^b   Mantero, F ^a   Scaroni, Carla ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

Cushing's syndrome; Intimal media thickness

Indexed keywords

ANTIHYPERTENSIVE AGENT; DESMOPRESSIN; GLUCOSE; HOMOCYSTEINE; HYDROCORTISONE; INSULIN; LIPID; LIPOPROTEIN; ORAL ANTIDIABETIC AGENT;

ADOLESCENT; ADULT; AGED; AORTA; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL DIAMETER; BLOOD VESSEL WALL; BODY MASS; CARDIOVASCULAR RISK; CAROTID ARTERY; CIGARETTE SMOKING; CLINICAL ARTICLE; COMMON CAROTID ARTERY; CONTROLLED STUDY; CUSHING SYNDROME; DIABETES MELLITUS; DOPPLER ECHOGRAPHY; DOPPLER FLOWMETRY; FEMALE; FEMORAL ARTERY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HOMEOSTASIS; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERTENSION; INTIMA; LIPID METABOLISM; MALE; PRIORITY JOURNAL; TUNICA MEDIA; WAIST HIP RATIO;

ADOLESCENT; ADULT; AGED; AORTA; ATHEROSCLEROSIS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CUSHING SYNDROME; FEMALE; FEMORAL ARTERY; HOMOCYSTEINE; HUMANS; LIPIDS; LIPOPROTEIN(A); MALE; MIDDLE AGED; RESEARCH DESIGN; RISK FACTORS; TUNICA INTIMA; TUNICA MEDIA;

EID: 33745927396     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-944545     Document Type: Article

References (25)

1. Aron DC, Blinding JW, Tyrrel JB. Cushing's disease. Endocrinol Metab Clin North Am 1987; 16: 705-730
2. Terzolo M, Pia A, Ali A, Osella G, Reimondo G, Bovio S, Daffara F, Procopio M, Paccotti P, Borretta G, Angeli A. Adrenal incidentaloma: a new cause of the metabolic syndrome? J Clin Endocrinol Metab 2002; 87; 998-1003
3. Findling JW, Raff H. Diagnosis and differential diagnosis of Cushing's syndrome. Endocrinol Metab Clin North Am 2001; 30: 729-747
4. Leibowitz G, Tsur A, Chayen SD, Salameh M, Raz I, Cerasi E, Gross DJ. Pre-clinical Cushing's syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients. Clin Endocrinol (Oxf) 1996; 44: 717-722
5. Contreras LN, Cardoso E, Lozano MP, Pozzo J, Pagano P, Claus-Hermbeg H. Deteccion de sindrome de Cushing preclinico en pacientes con sobrepeso y diabetes mellitus tipo 2. Medicina 2000; 60: 326-330
6. Etxabe J, Vazquez JA. Morbidity and mortality in Cushing's disease: an epidemiological approach. CHn Endocrinol (Oxf) 1994; 40: 479-484
7. Pivonello R, Faggiano A, Lombardi G, Colao A. The metabolic syndrome and cardiovascular risk in Cushing's syndrome. Endocrinol Metab Clin N Am 2005; 34: 327-339
8. O'Leary DH, Polak JF, Kronmal RA, Savage PJ, Borhani NO, Kittner SJ, Tracy R, Gardin JM, Price TR, Furberg CD. Thickening of the carotid wall. A marker for atherosclerosis in the elderly? Cardiovascular Health Study Collaborative Research Group. Stroke 1996; Feb 27: 224-231
9. Lekakis JP, Papamichael CM, Cimponeriu AT, Lekakis JP, Papamichael CM, Cimponeriu AT, Stamatelopoulos KS, Papaioannou TG, Kanakakis J, Alevizaki MK, Papapanagiotou A, Kalofoutis AT, Stamatelopoulos SF. Atherosclerotic changes of extracoronary arteries are associated with the extent of coronary atherosclerosis. Am J Cardiol 2000; 85: 949-952
10. Faggiano A, Pivonello R, Spiezia S, De Martino MC, Filippella MG, Di Somma C, Lombardi G, Colao A. Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission. J Clin Endocrinol Metab 2003; 88: 2527-2533
11. Colao A, Pivonello R, Spiezia S, Faggiano A, Ferone D, Filippella M, Marzullo P, Cerbone G, Sicilian! M, Lombardi G. Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. J Clin Endocrinol Metab 1999; 84: 2664-2672
12. Chalmers J. WHO-ISH Hypertension Guidelines Committee 1999. World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertension 1999; 17: 151-185
13. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 2000; 28: 412-419
14. Emoto M, Nishizawa Y, Maekawa K, Hiura Y, Kanda H, Kawagishi T, Shoji T, Okuno Y, Morii H. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes care 1999; 22: 818-822
15. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimai plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986; 74: 1399-1406
16. Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, Rankin RN, Clagett GP, Hachinski VC, Sacket DL, Thorpe KE, Meldrum HE, Spence JD. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1998; 339: 1415-1425
17. Rebuffé-Scrive M, Lundholm K, Björntorp P. Glucocorticoid hormone binding to human adipose tissue. Eur J Clin Invest 1985; 15: 267-271
18. Bujalska IJ, Kumar S, Stewart PM. Does central obesity reflect "Cushing's disease of the omentum"? Lancet 1997; 349: 1210-1213
19. Steinberg HO, Shaker H, Learning R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 1996; 97: 2601-2610
20. Denis CV. Von Willebrand factor in vascular pathophysiology. Pathologie Biologie 2003; 51: 395-396
21. Ambrosi B, Sartorio A, Pizzocaro A, Passini E, Bottasso B, Federici A. Evaluation of haemostatic and fibrinolytic markers in patients with Cushing's syndrome and in patients with adrenal incidentaloma. Exp Clin Endocrinol Diabetes 2000; 108: 294-298
22. Kirilov G, Tomova A, Dakovska L, Kumanov Ph, Shinkov A, Alexandrov AS. Elevated plasma endothelin as an additional cardiovascular risk factor in patients with Cushing's syndrome. European J Endocrinol 2003; 149: 549-553
23. Kelly JJ, Mangos G, Williamson PM, WhitworthJA. Cortisol and hypertension. Clin Exp Pharmacol Physiol 1998; 25 (Suppl): S51-S56
24. Healey B. Endothelial cell dysfunction: an emerging endocrinopathy linked to coronary disease. J Am Coll Cardiol 1990; 16: 357-358
25. Zacharieva S, Atanassova I, Nachev E, Orbetzova M, Kirilov G, Kalinov K, Shigarminova R. Markers of vascular function in hypertension due to Cushing's syndrome. Horm Metab Res 2005; 37: 36-39